Insider sale
TAYSHA GENE THERAPIES, INC.
$79.2K
27.59K shares
What this filing means
MCAULIFFE SEAN plans to sell 27.59K shares of TAYSHA GENE THERAPIES, INC. valued at approximately $79.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/21/2025ACC: 0001415889-25-022683
27.59K
Shares to sell
$79.2K
Approx. market value
27.59K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
RSU Award
Vested grant settled instock; consideration was Reporting Person's continued service as an employee ofthe Issuer.
8/21/2025
27.59KTotal acquired27.59K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/21/2025 | RSU Award Vested grant settled instock; consideration was Reporting Person's continued service as an employee ofthe Issuer. | 27.59K | — |
| Total | 27.59K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
27.59K
Market value
$79.2K
8/21/2025
Total
Units
27.59K
Value
$79.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/21/2025 | 27.59K | $79.2K | Nasdaq | Planned |
| Total | 27.59K | $79.2K | ||